XML 125 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2022 $ 139,000 $ 319,766,000 $ (194,343,000) $ 125,562,000 $ 31,119,000 $ 156,681,000
Beginning balance, shares at Dec. 31, 2022 6,950,858          
Stock based payments $ 1,000 267,000 268,000 268,000
Stock based payments, shares 62,350            
Dividend in kind - Deconsolidation of Sharing Services Global Corporation (1,206,000) (1,206,000) (1,206,000)
Deconsolidation of Sharing Services   5,064,000 5,064,000
Net loss (30,325,000) (30,325,000) (2,736,000) (33,061,000)
Ending balance, value at Sep. 30, 2023 $ 140,000 320,033,000 (225,874,000) 94,299,000 33,447,000 127,746,000
Ending balance, shares at Sep. 30, 2023 7,013,208          
Beginning balance, value at Dec. 31, 2023 $ 140,000 319,963,000 (256,176,000) 63,927,000 19,287,000 83,214,000
Beginning balance, shares at Dec. 31, 2023 7,066,772          
Net loss (14,034,000) (14,034,000) (1,728,000) (15,762,000)
Initial public offering of Impact BioMedical 1,000 2,226,000 2,227,000 2,227,000
Ending balance, value at Sep. 30, 2024 $ 141,000 $ 322,189,000 $ (270,210,000) $ 52,120,000 $ 17,559,000 $ 69,679,000
Ending balance, shares at Sep. 30, 2024 7,066,772